The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
Open accessAbstract
Key to the pharmaceutical utility of certain macrocyclic drugs is a “chameleonic” ability to change their conformation to expose polar groups in aqueous solution, but bury them when traversing lipid membranes. Based on analysis of the structures of 20 macrocyclic compounds that are approved oral drugs, we propose that good solubility requires a topological polar surface area (TPSA, in Å2) of ≥0.2 × MW. Meanwhile, good passive membrane permeability requires a molecular (i.e. 3D) PSA in nonpolar environments of ≤140 Å2. We show that one or other of these limits is almost invariably violated for compounds with MW > 600 Da., suggesting that some degree of chameleonic behavior is required for most high MW oral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Self-citationCharacteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Assessing drug-likeness – what are we missing?
Vistoli, G., Pedretti, A., & Testa, B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.007 · Cited by 278
El Tayar, N., Mark, A. E., Vallat, P., Brunne, R. M., Testa, B., & van Gunsteren, W. F. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00076a002 · Cited by 215
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M., Jacobson, M. P., & Lokey, R. S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 210
Kipps, T. J., Eradat, H., Grosicki, S., Catalano, J., Cosolo, W., Dyagil, I. S., Yalamanchili, S., Chai, A., Sahasranaman, S., Punnoose, E., et al. (2015) · Leukemia & Lymphoma · doi:10.3109/10428194.2015.1030638 · Cited by 196
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Bockus, A. T., McEwen, C. M., & Lokey, R. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070005 · Cited by 187
Bockus, A. T., Lexa, K. W., Pye, C. R., Kalgutkar, A. S. S., Gardner, J. W., Hund, K. C. R., Hewitt, W. M., Schwochert, J. A., Glassey, E., Price, D. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00128 · Cited by 147
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
Recent Advances on Aqueous Solubility Prediction
Wang, J., & Hou, T. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795508331 · Cited by 128
Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation
Guimarães, C. R. W., Mathiowetz, A. M., Shalaeva, M. Y., Goetz, G. H., & Liras, S. I. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300010y · Cited by 117
Roberts, A. W., Advani, R. H., Kahl, B. S., Persky, D. O., Sweetenham, J. W., Carney, D. A., Yang, J., Busman, T. A., Enschede, S. H., Humerickhouse, R., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13487 · Cited by 101
Levin, J. I. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623113 · Cited by 76
Aqueous Solubility Prediction: Do Crystal Lattice Interactions Help?
Salahinejad, M., Le, T. C., & Winkler, D. A. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001958 · Cited by 69
Cited by
Tetrazoles via Multicomponent Reactions
Neochoritis, C. G., Zhao, T., & Dömling, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00564 · Cited by 599
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection: Miniperspective
DeGoey, D. A., Chen, H.-J., Cox, P. B., & Wendt, M. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00717 · Cited by 378
Macrocycles in Drug Discovery─Learning from the Past for the Future
Garcia Jimenez, D., Poongavanam, V., & Kihlberg, J. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00134 · Cited by 321
How Big Is Too Big for Cell Permeability?
Matsson, P., & Kihlberg, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00237 · Cited by 303
Metadata
- Authors
- Whitty, A., Zhong, M., Viarengo, L., Beglov, D., Hall, D. R., & Vajda, S.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 21
- Issue
- 5
- Pages
- 712-717
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2279263454
- Cited by
- 285
- References
- 26
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.